πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,328 results for β€œChina” Clear

  1. golidocitinib

    China SXT Pharmaceuticals

    Peripheral T Cell Lymphoma

    phase 3 small molecule active

    1 trial

  2. internal mammary nodal irradiation

    China SXT Pharmaceuticals

    Breast Cancer

    phase 3 other active

    1 trial

  3. mCapOX plus Cetuximab

    China SXT Pharmaceuticals

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  4. misoprostol

    China SXT Pharmaceuticals

    Labor Induction

    phase 3 small molecule completed

    1 trial

  5. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    China SXT Pharmaceuticals

    Hepatocellular Carcinoma

    phase 3 other active

    1 trial

  6. mosapride citrate

    China SXT Pharmaceuticals

    Constipation

    phase 3 small molecule completed

    1 trial

  7. neoadjuvant chemotherapy

    China SXT Pharmaceuticals

    Epithelial Ovarian Cancer

    phase 3 small molecule active

    1 trial

  8. novel stent

    China SXT Pharmaceuticals

    Esophageal Cancer

    phase 3 other active

    1 trial

  9. patients were assigned to receive TNT or iTNT management

    China SXT Pharmaceuticals

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  10. poliovirus vaccine

    China SXT Pharmaceuticals

    Poliomyelitis

    phase 3 mab completed

    1 trial

  11. pralatrexate

    China SXT Pharmaceuticals

    Refractory Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  12. preoperative short-course radiotherapy

    China SXT Pharmaceuticals

    Rectal Neoplasms

    phase 3 other terminated

    1 trial

  13. recombinant human thrombopoietin (rhTPO); dexamethasone

    China SXT Pharmaceuticals

    Purpura

    phase 3 small molecule completed

    1 trial

  14. recombinant human thrombopoietin (rhTPO); rituximab

    China SXT Pharmaceuticals

    Purpura

    phase 3 small molecule terminated

    1 trial

  15. rhTPO in combination with Rituximab

    China SXT Pharmaceuticals

    Purpura

    phase 3 small molecule completed

    1 trial

  16. rituximab; recombinant human thrombopoietin (rhTPO)

    China SXT Pharmaceuticals

    Purpura

    phase 3 small molecule completed

    1 trial

  17. shenfu injection

    China SXT Pharmaceuticals

    Septic Shock

    phase 3 small molecule active

    1 trial

  18. six courses of zanubrutinib, rituximab and lenalidomide

    China SXT Pharmaceuticals

    Diffuse Large B-Cell Lymphoma

    phase 3 small molecule active

    1 trial

  19. tacrolimus capsule

    China SXT Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule terminated

    1 trial

  20. toripalimab

    China SXT Pharmaceuticals

    Esophageal Cancer

    phase 3 small molecule active

    1 trial

  21. urapidil

    China SXT Pharmaceuticals

    Stroke, Acute

    phase 3 small molecule completed

    1 trial

  22. 0.2mg group

    China SXT Pharmaceuticals

    Opioid Dependence

    phase 2 small molecule active

    1 trial

  23. 16mg，KB

    China SXT Pharmaceuticals

    Sepsis

    phase 2 small molecule active

    1 trial

  24. 1ΞΌg/ml ESAT6-CFP10 and tuberculin purified protein derivative

    China SXT Pharmaceuticals

    Tuberculosis

    phase 2 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources